Form 4: Labcorp Director Kerrii B. Anderson Sells 1,000 Shares Under 10b5-1 Plan

Labcorp director Kerrii B. Anderson sold 1,000 shares of common stock at $235 per share on January 7, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Kerrii B. Anderson, a director at Labcorp Holdings Inc., sold 1,000 shares of common stock on January 7, 2025.
• The sale was executed at a price of $235 per share.
• This transaction was conducted under a pre-arranged trading plan that complies with Rule 10b5-1 of the Securities Exchange Act of 1934.
• Following the transaction, Ms. Anderson directly owns 12,722 shares of Labcorp common stock.
• She also indirectly owns 144 shares through the Alexa M. Anderson Separate Trust and 144 shares through the Cameron Taff Anderson Separate Trust.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of a pre-planned stock sale by a director. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity. It is common for directors and officers to have pre-arranged trading plans to avoid accusations of trading on inside information.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The use of a 10b5-1 trading plan is a common method for corporate insiders to sell shares while avoiding accusations of insider trading.
• The transaction is consistent with typical insider trading activity and does not indicate any unusual behavior.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the stock price due to the pre-planned nature of the transaction.

Key Dates

Keywords

Labcorp, insider trading, Form 4, 10b5-1 plan, stock sale, director, equity securities